Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

NCT03523975 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Venetoclax
DRUG: Lenalidomide
DRUG: Rituximab

Sponsor

City of Hope Medical Center